Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Immunoclin Corp | form8k.htm |
July 7, 2014
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
We have read the statements of ImmunoClin Corporation pertaining to our firm included under Item 4.01 of Form 8-K dated January 7, 2014, and agree with such statements as they pertain to our firm.
Sincerely,
/s/ Sadler, Gibb & Associates, LLC